Certificate of Analysis
CP10 (CJC-1295 / Ipamorelin) · 10 mg
- Catalogue no.
- CP10-10
- Lot / batch
- ZV-CP10-1825
- Physical form
- Lyophilized blend
- Manufacture date
- 2026-03-17
- Release date
- 2026-03-31
- Retest date
- 2028-03-16
| Test | Method | Specification | Result |
|---|---|---|---|
| Appearance | Visual | White to off-white lyophilized powder | Conforms |
| Identity (molecular mass) | ESI-MS | Consistent with theoretical mass | Conforms |
| Purity (chromatographic) | RP-HPLC, UV 214 nm | ≥98% | 99.15 % |
| Single largest impurity | RP-HPLC, UV 214 nm | ≤ 0.50 % | 0.34 % |
| Water content | Karl Fischer | ≤ 8.0 % | 0.78 % |
| Counter-ion (acetate) | Ion chromatography | ≤ 15.0 % | 2.69 % |
| Net compound content | Gravimetric / UV | 10 mg | 10 mg |
| Bacterial endotoxins | LAL kinetic chromogenic | Report result | < 0.5 EU/mg |
| Solubility | Bacteriostatic water reconstitution | Clear solution, no visible particulates | Conforms |
Storage and handling
Store sealed at -20 °C, protected from light and moisture
Statement of conformity
The lot identified above was tested against the listed specifications and conforms to all release criteria. This material is supplied strictly as a research chemical for in vitro laboratory investigation. It is not a drug, food, cosmetic, or natural health product, holds no DIN or NPN, is not approved by the FDA or Health Canada, and must not be administered to humans or animals.